Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 6, 1994 - Issue 2
44
Views
46
CrossRef citations to date
0
Altmetric
Original Articles

Methadone treatment as a determinant of HIV risk reduction among injecting drug users: A nested case-control study

, , , , &
Pages 215-220 | Published online: 25 Sep 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Mei Wang, Wenwen Mao, Linglin Zhang, Baofa Jiang, Yan Xiao, Yujiang Jia, Pingsheng Wu, Holly Cassell & Sten Vermund. (2015) Methadone Maintenance Therapy and HIV Counseling and Testing are Associated with Lower frequency of Risky Behaviors Among Injection Drug Users in China. Substance Use & Misuse 50:1, pages 15-23.
Read now
Lin Zhao, William L. Holzemer, Jacqueline P. Tulsky, Mallory O. Johnson & Carol Dawson Rose. (2014) Effect of Methadone Dose on Maintenance Treatment and Health Consequences Among Heroin Addicts in South China. Substance Use & Misuse 49:1-2, pages 13-21.
Read now
Elise D. Riley, Mahboobeh Safaeian, Steffanie A. Strathdee, Robert K. Brooner, Peter Beilenson & David Vlahov. (2002) DRUG USER TREATMENT REFERRALS AND ENTRY AMONG PARTICIPANTS OF A NEEDLE EXCHANGE PROGRAM. Substance Use & Misuse 37:14, pages 1869-1886.
Read now
DavidP. Desmond & JamesF. Maddux. (2000) Deaths Among Heroin Users in and out of Methadone Treatment. Journal of Maintenance in the Addictions 1:4, pages 45-61.
Read now
HarryW. Haverkos. (1998) HIV/AIDS and Drug Abuse: Epidemiology and Prevention. Journal of Addictive Diseases 17:4, pages 91-103.
Read now
Luciano Sagliocca, Giovanni Rezza, David Vlahov, Clara Baldassarre, Marina Siconolfi, Matteo Nespoli & Patrizia Carriers. (1997) A Morphine Prescription Program in Italy (1980-1985): Retrospective Evidence of Protection Against Hiv/Aids. Addiction Research 5:2, pages 137-144.
Read now
Steven L. Batki & Stephen J. Ferrando. (1996) Diagnosis and treatment of substance use disorders in patients with HIV infection. International Review of Psychiatry 8:2-3, pages 245-252.
Read now
Giovanni Rezza, Luciano Sagliocca, Mauro Zaccarell, Matteo Nespoli, Marina Siconolfi & Clara Baldassarre. (1996) Incidence Rate and Risk Factors for HCV Seroconversion Among Injecting Drug Users in an Area with Low HIV Seroprevalence. Scandinavian Journal of Infectious Diseases 28:1, pages 27-29.
Read now
John R. M. Caplehorn & Michael W. Ross. (1995) Methadone Maintenance and the Likelihood of Risky Needle-Sharing. International Journal of the Addictions 30:6, pages 685-698.
Read now

Articles from other publishers (36)

K. Michelle Peavy, James Darnton, Paul Grekin, Monica Russo, Caleb J. Banta Green, Joseph O. Merrill, Charissa Fotinos, Steve Woolworth, Sean Soth & Judith I. Tsui. (2020) Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program. AIDS and Behavior 24:9, pages 2469-2472.
Crossref
Yu-Ching Huang, Yen-Fang Huang, Min-Hau Lin, Jyh-Yuan Yang, Yu-Hsin Liao, Hsiu-Yun Lo, Carl Latkin & Kenrad E. Nelson. (2019) An outbreak of HIV infection among people who inject drugs linked to injection of propofol in Taiwan. PLOS ONE 14:2, pages e0210210.
Crossref
George E. Woody, Douglas Bruce, P. Todd Korthuis, Sumedha Chhatre, Sabrina Poole, Maureen Hillhouse, Petra Jacobs, James Sorensen, Andrew J. Saxon, David Metzger & Walter Ling. (2014) HIV Risk Reduction With Buprenorphine–Naloxone or Methadone. JAIDS Journal of Acquired Immune Deficiency Syndromes 66:3, pages 288-293.
Crossref
Yen-Fang Huang, Jyh-Yuan Yang, Kenrad E. Nelson, Hsu-Sung Kuo, Chin-Yin Lew-Ting, Chin-Hui Yang, Chang-Hsun Chen, Feng-Yee Chang & Hui-Rong Liu. (2014) Changes in HIV Incidence among People Who Inject Drugs in Taiwan following Introduction of a Harm Reduction Program: A Study of Two Cohorts. PLoS Medicine 11:4, pages e1001625.
Crossref
Georgina J. MacArthur, Eva van Velzen, Norah Palmateer, Jo Kimber, Anastasia Pharris, Vivian Hope, Avril Taylor, Kirsty Roy, Esther Aspinall, David Goldberg, Tim Rhodes, Dagmar Hedrich, Mika Salminen, Matthew Hickman & Sharon J. Hutchinson. (2014) Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness. International Journal of Drug Policy 25:1, pages 34-52.
Crossref
Jeannia J. Fu, Nickolas D. Zaller, Michael A. Yokell, Alexander R. Bazazi & Josiah D. Rich. (2013) Forced withdrawal from methadone maintenance therapy in criminal justice settings: A critical treatment barrier in the United States. Journal of Substance Abuse Treatment 44:5, pages 502-505.
Crossref
Linda Gowing, Michael F Farrell, Reinhard Bornemann, Lynn E Sullivan & Robert Ali. (2011) Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews.
Crossref
David S Metzger, George E Woody & Charles P O'Brien. (2010) Drug Treatment as HIV Prevention: A Research Update. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:Supplement 1, pages S32-S36.
Crossref
Curt G Beckwith, Nickolas D Zaller, Jeannia J Fu, Brian T Montague & Josiah D Rich. (2010) Opportunities to Diagnose, Treat, and Prevent HIV in the Criminal Justice System. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:Supplement 1, pages S49-S55.
Crossref
Kenneth M. Dürsteler-MacFarland, Dominique A. Fischer, Sandra Mueller, Otto Schmid, Andreas Moldovanyi & Gerhard A. Wiesbeck. (2010) Symptom complaints of patients prescribed either oral methadone or injectable heroin. Journal of Substance Abuse Treatment 38:4, pages 328-337.
Crossref
Alex Wodak & Lisa Maher. (2010) The effectiveness of harm reduction in preventing HIV among injecting drug users. New South Wales Public Health Bulletin 21:4, pages 69.
Crossref
Jeff Ward, Wayne Hall & Richard Mattick. 2009. Pharmacotherapies for the Treatment of Opioid Dependence. Pharmacotherapies for the Treatment of Opioid Dependence 107 141 .
Linda Gowing, Michael Farrell, Reinhard Bornemann, Lynn E Sullivan & Robert Ali. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
M. P. Carrieri, L. Amass, G. M. Lucas, D. Vlahov, A. Wodak & G. E. Woody. (2006) Buprenorphine Use: The International Experience. Clinical Infectious Diseases 43:Supplement 4, pages S197-S215.
Crossref
Susanne Y.P. Choi, Yuet Wah Cheung & Kanglin Chen. (2006) Gender and HIV risk behavior among intravenous drug users in Sichuan Province, China. Social Science & Medicine 62:7, pages 1672-1684.
Crossref
Linda R. Gowing, Michael Farrell, Reinhard Bornemann, Lynn E. Sullivan & Robert L. Ali. (2006) Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection. Journal of General Internal Medicine 21:2, pages 193-195.
Crossref
Lynn E. Sullivan, David S. Metzger, Paul J. Fudala & David A. Fiellin. (2005) Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction 100:2, pages 150-158.
Crossref
Dennis Deck & Matthew J. Carlson. (2005) Retention in Publicly Funded Methadone Maintenance Treatment in Two Western States. The Journal of Behavioral Health Services & Research 32:1, pages 43???60.
Crossref
Dennis Deck & Matthew J. Carlson. (2005) Retention in publicly funded methadone maintenance treatment in two western states. The Journal of Behavioral Health Services & Research 32:1, pages 43-60.
Crossref
Linda Gowing, Michael Farrell, Robert Ali & Jason M White. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
. (2004) Recommendations for Incorporating Human Immunodeficiency Virus (HIV) Prevention into the Medical Care of Persons Living with HIV. Clinical Infectious Diseases 38:1, pages 104-121.
Crossref
David S. Metzger & Helen Navaline. (2003) Human Immunodeficiency Virus Prevention and the Potential of Drug Abuse Treatment. Clinical Infectious Diseases 37:s5, pages S451-S456.
Crossref
Robert Heimer, Sarah Bray, Scott Burris, Kaveh Khoshnood & Kim M. Blankenship. (2002) Structural interventions to improve opiate maintenance. International Journal of Drug Policy 13:2, pages 103-111.
Crossref
Petrie M. Rainey, Gerald H. Friedland, Jerry W. Snidow, Elinore F. McCance‐Katz, Susan M. Mitchell, Laurie Andrews, Barbara Lane & Peter Jatlow. (2010) The Pharmacokinetics of Methadone Following Co‐Administration with a Lamivudine/Zidovudine Combination Tablet in Opiate‐Dependent Subjects. The American Journal on Addictions 11:1, pages 66-74.
Crossref
Arthur I. Alterman, Charles P. O’Brien, A. Thomas McLellan & James R. McKay. 2001. Comprehensive Handbook of Psychopathology. Comprehensive Handbook of Psychopathology 623 640 .
Maureen Miller & Alan Neaigus. (2001) Networks, resources and risk among women who use drugs. Social Science & Medicine 52:6, pages 967-978.
Crossref
Miranda W. Langendam, Giel H. A. van Brussel, Roel A. Coutinho & Erik J. C. van Ameijden. (2000) Trends in HIV risk behaviour and methadone dosage among HIV-negative drug users: an ecological study. AIDS 14:12, pages 1870-1872.
Crossref
. (2000) HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health 90:7, pages 1100-1111.
Crossref
James L. Sorensen & Amy L. Copeland. (2000) Drug abuse treatment as an HIV prevention strategy: a review. Drug and Alcohol Dependence 59:1, pages 17-31.
Crossref
David S. Metzger, Helen Navaline & George E. Woody. 2000. Handbook of HIV Prevention. Handbook of HIV Prevention 147 157 .
David R. Gibson, Neil M. Flynn & John J. McCarthy. (1999) Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 13:14, pages 1807-1818.
Crossref
Miranda W. Langendam, Giel H.A. van Brussel, Roel A. Coutinho & Erik J.C. van Ameijden. (1999) Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study. AIDS 13:13, pages 1711-1716.
Crossref
Rita Aszalos, David R McDuff, Eric Weintraub, Ivan Montoya & Robert Schwartz. (1999) Engaging Hospitalized Heroin-Dependent Patients Into Substance Abuse Treatment. Journal of Substance Abuse Treatment 17:1-2, pages 149-158.
Crossref
Maureen Miller & Denise Paone. (1998) Social network characteristics as mediators in the relationship between sexual abuse and HIV risk. Social Science & Medicine 47:6, pages 765-777.
Crossref
Christine E. Grella, Stuart E. Wugalter & M. Douglas Anglin. (1997) Predictors of Treatment Retention in Enhanced and Standard Methadone Maintenance Treatment for HIV Risk Reduction. Journal of Drug Issues 27:2, pages 203-224.
Crossref
Christine E. Grella, M.Douglas Anglin, Richard Rawson, Robert Crowley & Albert Hasson. (1996) What happens when a demonstration project ends. Journal of Substance Abuse Treatment 13:3, pages 249-256.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.